Incyte Corp (INCY)
54.89
-3.97
(-6.74%)
USD |
NASDAQ |
Apr 10, 13:41
Incyte Shareholders Equity (Quarterly): 3.448B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.19B |
| Gilead Sciences Inc | 19.33B |
| Syndax Pharmaceuticals Inc | 288.12M |
| Halozyme Therapeutics Inc | 363.82M |
| Regeneron Pharmaceuticals Inc | 29.35B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.444B |
| Total Liabilities (Quarterly) | 1.997B |
| Current Ratio | 1.973 |